1. Home
  2. BLDR vs CORT Comparison

BLDR vs CORT Comparison

Compare BLDR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Builders FirstSource Inc.

BLDR

Builders FirstSource Inc.

N/A

Current Price

$55.48

Market Cap

6.8B

ML Signal

N/A

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$64.83

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLDR
CORT
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
7.6B
IPO Year
2005
2001

Fundamental Metrics

Financial Performance
Metric
BLDR
CORT
Price
$55.48
$64.83
Analyst Decision
Hold
Buy
Analyst Count
24
5
Target Price
$67.50
★ $142.60
AVG Volume (30 Days)
★ 2.4M
1.2M
Earning Date
10-29-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
0.08
★ 1.13
Revenue
★ $15,190,638,000.00
$761,407,000.00
Revenue This Year
N/A
$52.09
Revenue Next Year
N/A
$44.73
P/E Ratio
$716.13
★ $59.79
Revenue Growth
N/A
★ 12.79
52 Week Low
$49.67
$28.66
52 Week High
$131.50
$126.38

Technical Indicators

Market Signals
Indicator
BLDR
CORT
Relative Strength Index (RSI) 41.73 21.65
Support Level $49.67 $30.24
Resistance Level $78.13 $122.93
Average True Range (ATR) 3.22 4.81
MACD -0.89 -0.10
Stochastic Oscillator 0.30 2.23

Price Performance

Historical Comparison
BLDR
CORT

About BLDR Builders FirstSource Inc.

Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: